The ratio of IL10 to IFNγ produced by the Tr1-like cytotoxic CD4 T cells could be a key determinant in whether Tr1-like cytotoxic CD4 T cells have a net pro-tumor or anti-tumor impact (summarized in Figure 2). The gene discussed is IL10; the disease is neoplasm.